Literature DB >> 22031935

Ligand-bound structures of the dengue virus protease reveal the active conformation.

Christian G Noble1, Cheah Chen Seh, Alexander T Chao, Pei Yong Shi.   

Abstract

Dengue is a mosquito-borne viral hemorrhagic disease that is a major threat to human health in tropical and subtropical regions. Here we report crystal structures of a peptide covalently bound to dengue virus serotype 3 (DENV-3) protease as well as the serine-protease inhibitor aprotinin bound to the same enzyme. These structures reveal, for the first time, a catalytically active, closed conformation of the DENV protease. In the presence of the peptide, the DENV-3 protease forms the closed conformation in which the hydrophilic β-hairpin region of NS2B wraps around the NS3 protease core, in a manner analogous to the structure of West Nile virus (WNV) protease. Our results confirm that flavivirus proteases form the closed conformation during proteolysis, as previously proposed for WNV. The current DENV-3 protease structures reveal the detailed interactions at the P4' to P3 sites of the substrate. The new structural information explains the sequence preference, particularly for long basic residues in the nonprime side, as well as the difference in substrate specificity between the WNV and DENV proteases at the prime side. Structural analysis of the DENV-3 protease-peptide complex revealed a pocket that is formed by residues from NS2B and NS3; this pocket also exists in the WNV NS2B/NS3 protease structure and could be targeted for potential antivirus development. The structural information presented in the current study is invaluable for the design of specific inhibitors of DENV protease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22031935      PMCID: PMC3255909          DOI: 10.1128/JVI.06225-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

2.  Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries.

Authors:  Jun Li; Siew Pheng Lim; David Beer; Viral Patel; Daying Wen; Christine Tumanut; David C Tully; Jennifer A Williams; Jan Jiricek; John P Priestle; Jennifer L Harris; Subhash G Vasudevan
Journal:  J Biol Chem       Date:  2005-06-01       Impact factor: 5.157

3.  Generation and characterization of proteolytically active and highly stable truncated and full-length recombinant West Nile virus NS3.

Authors:  Keith J Chappell; Martin J Stoermer; David P Fairlie; Paul R Young
Journal:  Protein Expr Purif       Date:  2006-11-07       Impact factor: 1.650

4.  Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies.

Authors:  Keith J Chappell; Martin J Stoermer; David P Fairlie; Paul R Young
Journal:  J Biol Chem       Date:  2006-10-19       Impact factor: 5.157

5.  Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.

Authors:  Paul Erbel; Nikolaus Schiering; Allan D'Arcy; Martin Renatus; Markus Kroemer; Siew Pheng Lim; Zheng Yin; Thomas H Keller; Subhash G Vasudevan; Ulrich Hommel
Journal:  Nat Struct Mol Biol       Date:  2006-03-12       Impact factor: 15.369

6.  Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.

Authors:  Sergey A Shiryaev; Igor A Kozlov; Boris I Ratnikov; Jeffrey W Smith; Michal Lebl; Alex Y Strongin
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

7.  Characterization of the West Nile virus protease substrate specificity and inhibitors.

Authors:  Niklaus H Mueller; Changsuek Yon; Vannakambadi K Ganesh; R Padmanabhan
Journal:  Int J Biochem Cell Biol       Date:  2006-11-23       Impact factor: 5.085

8.  Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors.

Authors:  Zheng Yin; Sejal J Patel; Wei-Ling Wang; Wai-Ling Chan; K R Ranga Rao; Gang Wang; Xinyi Ngew; Viral Patel; David Beer; John E Knox; Ngai Ling Ma; Claus Ehrhardt; Siew Pheng Lim; Subhash G Vasudevan; Thomas H Keller
Journal:  Bioorg Med Chem Lett       Date:  2005-10-21       Impact factor: 2.823

9.  Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.

Authors:  Pornwaratt Niyomrattanakit; Sviatlana Yahorava; Ilze Mutule; Felikss Mutulis; Ramona Petrovska; Peteris Prusis; Gerd Katzenmeier; Jarl E S Wikberg
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

10.  Application of high-throughput technologies to a structural proteomics-type analysis of Bacillus anthracis.

Authors:  K Au; N S Berrow; E Blagova; I W Boucher; M P Boyle; J A Brannigan; L G Carter; T Dierks; G Folkers; R Grenha; K Harlos; R Kaptein; A K Kalliomaa; V M Levdikov; C Meier; N Milioti; O Moroz; A Müller; R J Owens; N Rzechorzek; S Sainsbury; D I Stuart; T S Walter; D G Waterman; A J Wilkinson; K S Wilson; N Zaccai; Robert M Esnouf; Mark J Fogg
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-09-19
View more
  63 in total

1.  Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.

Authors:  Deng-wei Wu; Fei Mao; Yan Ye; Jian Li; Chuan-lian Xu; Xiao-min Luo; Jing Chen; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2015-08-17       Impact factor: 6.150

2.  Drug discovery for the developing world: progress at the Novartis Institute for Tropical Diseases.

Authors:  Catherine L Jones; Bryan K S Yeung; Ujjini Manjunatha; Pei-Yong Shi; Christophe Bodenreider; Thierry T Diagana
Journal:  Nat Rev Drug Discov       Date:  2015-06       Impact factor: 84.694

3.  Context-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus Assembly.

Authors:  Laura A VanBlargan; Kaitlin A Davis; Kimberly A Dowd; David L Akey; Janet L Smith; Theodore C Pierson
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

4.  Conformational flexibility of DENV NS2B/NS3pro: from the inhibitor effect to the serotype influence.

Authors:  Erika Piccirillo; Benjamin Merget; Christoph A Sotriffer; Antonia T do Amaral
Journal:  J Comput Aided Mol Des       Date:  2016-02-29       Impact factor: 3.686

5.  C-terminal residue optimization and fragment merging: discovery of a potent Peptide-hybrid inhibitor of dengue protease.

Authors:  Mira A M Behnam; Christoph Nitsche; Sérgio M Vechi; Christian D Klein
Journal:  ACS Med Chem Lett       Date:  2014-07-18       Impact factor: 4.345

Review 6.  Functional interplay among the flavivirus NS3 protease, helicase, and cofactors.

Authors:  Kuohan Li; Wint Wint Phoo; Dahai Luo
Journal:  Virol Sin       Date:  2014-03-26       Impact factor: 4.327

7.  Covalent Antiviral Agents.

Authors:  Sako Mirzaie; Fatemeh Abdi; Amin GhavamiNejad; Brian Lu; Xiao Yu Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond.

Authors:  Veaceslav Boldescu; Mira A M Behnam; Nikos Vasilakis; Christian D Klein
Journal:  Nat Rev Drug Discov       Date:  2017-05-05       Impact factor: 84.694

9.  Novel dengue virus NS2B/NS3 protease inhibitors.

Authors:  Hongmei Wu; Stefanie Bock; Mariya Snitko; Thilo Berger; Thomas Weidner; Steven Holloway; Manuel Kanitz; Wibke E Diederich; Holger Steuber; Christof Walter; Daniela Hofmann; Benedikt Weißbrich; Ralf Spannaus; Eliana G Acosta; Ralf Bartenschlager; Bernd Engels; Tanja Schirmeister; Jochen Bodem
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

10.  Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)-one and 1,3,4-oxadiazole hybrid derivatives: potent inhibitors of Dengue and West Nile virus NS2B/NS3 proteases.

Authors:  Huiguo Lai; Dengfeng Dou; Sridhar Aravapalli; Tadahisa Teramoto; Gerald H Lushington; Tom M Mwania; Kevin R Alliston; David M Eichhorn; Radhakrishnan Padmanabhan; William C Groutas
Journal:  Bioorg Med Chem       Date:  2012-11-15       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.